Obesity News and Research

Latest Obesity News and Research

Unhealthy maternal diet may lead to heart and diabetes risks in offspring

Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother.

16 Sep 2024

Higher soft drink consumption linked to increased risk of liver disease

Study found that higher soft drink consumption is associated with an increased risk of nonalcoholic fatty liver disease, especially in males, within a cohort of Mexican adults.

16 Sep 2024

Ketogenic diet restores menstrual cycles and boosts fertility in women with PCOS

A ketogenic diet restored menstrual cycles in all women with PCOS in a study, with over half of those desiring pregnancy achieving it. The diet could be a promising approach to enhance fertility.

15 Sep 2024

Real-world data reveals factors associated with long-term weight loss in obesity

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.

14 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

Research highlights gaps in evidence for lifestyle counseling in medicine

Healthcare professionals are increasingly giving advice to patients on how to improve their health, but there is often a lack of scientific evidence if this advice is actually beneficial.

13 Sep 2024

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Liraglutide treatment significantly lowers BMI in obese children aged 6 to <12, but gastrointestinal side effects prompt the need for additional studies.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

Researchers examine the role of GLP-2 in regulating food intake through its effects on gastrointestinal motility and satiety signals, offering insights into potential obesity treatments.

12 Sep 2024

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged.

12 Sep 2024

New tool ehrapy revolutionizes health data analysis

Led by Helmholtz Munich, scientists have developed an accessible software solution specifically designed for the analysis of complex medical health data.

12 Sep 2024

Swift management of gestational diabetes lowers child obesity rates

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.

12 Sep 2024

New IndiPHARM initiative aims to revolutionize personalized medication management

A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to prevent unwanted interactions between medications and other environmental, genetic, and lifestyle factors, in order to optimize therapeutic efficacy.

12 Sep 2024

Women experience greater weight loss with tirzepatide compared to men

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

11 Sep 2024

Endurance exercise transforms fat tissue and boosts metabolic health in adults with obesity

Regular endurance exercise significantly remodels abdominal subcutaneous fat in adults with obesity, enhancing its metabolic function and contributing to better cardiometabolic health.

11 Sep 2024

Atrial fibrillation affects more Americans than previously estimated

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million U.S. adults, according to new estimates from UC San Francisco.

11 Sep 2024

Brazilian research uncovers how liver nerves regulate glucose production under stress

A study led by Brazilian researchers has produced a detailed description of the morphology of the nerves in the liver and how they control production of glucose when the organism is under stress.

11 Sep 2024

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

Researchers reveal that obesity also increases the risk of contracting COVID-19 following exposure to SARS-CoV-2.

11 Sep 2024

Study links excess abdominal fat with widespread chronic pain

Excess abdominal fat is associated with widespread chronic pain, particularly in women, finds the first study of its kind, published in the open access journal Regional Anesthesia & Pain Medicine.

10 Sep 2024

Obesity medication liraglutide safe and effective in children under 12, research finds

The obesity medication liraglutide is safe and effective in children aged 6 to <12 years, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), and published simultaneously in the New England Journal of Medicine (NEJM), has found.

10 Sep 2024

Previous
1
...
11
12
13
14
15
16
17
...
1013
Next

Obesity News and Research

Latest Obesity News and Research

Unhealthy maternal diet may lead to heart and diabetes risks in offspring

Higher soft drink consumption linked to increased risk of liver disease

Ketogenic diet restores menstrual cycles and boosts fertility in women with PCOS

Real-world data reveals factors associated with long-term weight loss in obesity

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Research highlights gaps in evidence for lifestyle counseling in medicine

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

New tool ehrapy revolutionizes health data analysis

Swift management of gestational diabetes lowers child obesity rates

New IndiPHARM initiative aims to revolutionize personalized medication management

Women experience greater weight loss with tirzepatide compared to men

Endurance exercise transforms fat tissue and boosts metabolic health in adults with obesity

Atrial fibrillation affects more Americans than previously estimated

Brazilian research uncovers how liver nerves regulate glucose production under stress

Obesity increases risk of contracting COVID-19 after exposure to SARS-CoV-2

Study links excess abdominal fat with widespread chronic pain

Obesity medication liraglutide safe and effective in children under 12, research finds

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Obesity News and Research

Latest Obesity News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in